The chance that a good idea will eventually produce a commercially viable product is smaller than you might think. Especially when it comes to innovations in the biomedical world or alternatives to fossil fuels. Chemelot InSciTe lends a helping hand.
In the recent edition of newspaper De Limburger, managing director Emiel Staring explains what the Chemelot Institute for Science & Technology actually does.
'Chemelot InSciTe can actually be compared to a landlady in a dorm. A very special one, which not only provides a roof over your head, but also does everything in its power to ensure that the residents can develop to their full potential. So that the ideas they bring with them ultimately result in products that the world needs and for which, not unimportantly, there is a market.'
Chemelot InSciTe is, to put it more formally, a public-private partnership, initiated in 2014 by DSM, Eindhoven University of Technology, Maastricht University and Maastricht University Medical Centre+ and the Province of Limburg. More than five years later, the company has grown to 40 partners, including five universities. With a budget of 90 million euros, allocated to fifteen projects and invested in biomedical labs and a pilot plant.
Read the full article by De Limburger here: